← Leaderboards
Thomas M Wilkie
University Of Texas Sw Med Ctr/Dallas
$3,582,679
Attributed
$4,871,008
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $454.8K · FY2006–19$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,871,008 · 4
By mechanism
R01$4,500,975 · 2
R21$370,033 · 1
P50$0 · 1
Top collaborators
- Rolf A Brekken7 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- David R. Corey$14,676,470
- Masashi Yanagisawa$474,530
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypePathway InteractionsPharmaceutical PreparationsSignal PathwayRegulationResponseGene ExpressionFeedbackRgs ProteinsRgs Family GeneTranscription FactorTranscriptional RegulationMetabolicInsightSignal TransductionEventGeneticG-Protein-Coupled ReceptorsCellsAdultMalignant NeoplasmsMaintenanceCell TypeDuctal
Grant awards (18)
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA$420,093
R01 · FY2019 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA$454,817
R01 · FY2018 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA$454,817
R01 · FY2017 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA$435,921
R01 · FY2016 · CA
Exploitation of RAS signaling to develop therapy and early detection strategies for PDA$440,978
R01 · FY2015 · CA
GPCR regulation of progenitor cells in pancreatic cancer$162,538
R21 · FY2013 · CA
GPCR regulation of progenitor cells in pancreatic cancer$207,495
R21 · FY2012 · CA
GQ/11-RGS Mediated Signaling$293,461
R01 · FY2009 · GM · contact PI
GQ/11-RGS Mediated Signaling$293,461
R01 · FY2008 · GM · contact PI
GQ/11-RGS Mediated Signaling$293,461
R01 · FY2007 · GM · contact PI
GQ/11-RGS Mediated Signaling$302,225
R01 · FY2006 · GM · contact PI
GQ/11-RGS Mediated Signaling$45,993
R01 · FY2006 · GM · contact PI
GQ/RGS MEDIATED SIGNALING$279,410
R01 · FY2003 · GM
GQ/RGS MEDIATED SIGNALING$290,835
R01 · FY2002 · GM
GQ/RGS MEDIATED SIGNALING$11,903
R01 · FY2002 · GM
RGS proteins in appetitive circuits in mood /motivation$0
P50 · FY2002 · MH
GQ/RGS MEDIATED SIGNALING$241,800
R01 · FY2001 · GM
GQ/RGS MEDIATED SIGNALING$241,800
R01 · FY2000 · GM